-
1
-
-
0001146972
-
On the action of a secretion obtained from the medical leech on the coagulation of blood
-
Haycraft JB. On the action of a secretion obtained from the medical leech on the coagulation of blood. Proc Roy Soc London 1884; 36: 478.
-
(1884)
Proc Roy Soc London
, vol.36
, pp. 478
-
-
Haycraft, J.B.1
-
3
-
-
0011129947
-
Die antagonistische Wirkung des Hirudins gegen Thrombin in vivo
-
Markwardt F. Die antagonistische Wirkung des Hirudins gegen Thrombin in vivo. Naturwissenschaften 1956; 43: 111.
-
(1956)
Naturwissenschaften
, vol.43
, pp. 111
-
-
Markwardt, F.1
-
4
-
-
0000019735
-
Die Isolierung und chemische Charakterisierung des Hirudins
-
Markwardt F. Die Isolierung und chemische Charakterisierung des Hirudins. Hoppe Seylers Z Physiol Chem 1957; 308: 147-56.
-
(1957)
Hoppe Seylers Z Physiol Chem
, vol.308
, pp. 147-156
-
-
Markwardt, F.1
-
5
-
-
0014242234
-
Highly purified antithrombin III with heparin cofactor activity prepared by disc gel electrophoresis
-
Abildgaard U. Highly purified antithrombin III with heparin cofactor activity prepared by disc gel electrophoresis. Scand J Clin Lab Invest 1968; 21: 89-91.
-
(1968)
Scand J Clin Lab Invest
, vol.21
, pp. 89-91
-
-
Abildgaard, U.1
-
6
-
-
0000670405
-
Cloning and expression of cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis
-
Harvey RP, Degryse E, Stefani L, Schamber F, Cazenave J-P, Courteney M, Tolstoshev P, Lecocq J-P. Cloning and expression of cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis. Proc Natl Acad Sci USA 1986; 83: 1084-8.
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 1084-1088
-
-
Harvey, R.P.1
Degryse, E.2
Stefani, L.3
Schamber, F.4
Cazenave, J.-P.5
Courteney, M.6
Tolstoshev, P.7
Lecocq, J.-P.8
-
7
-
-
0022829882
-
Cloning and expression in Escherichia coli of a synthetic DNA for hirudin, the blood coagulation inhibitor in the leech
-
Fortkamp E, Reiger M, Heisterberg-Moustes G, Schweitzer S, Sommer R. Cloning and expression in Escherichia coli of a synthetic DNA for hirudin, the blood coagulation inhibitor in the leech. DNA 1986; 6: 511-7.
-
(1986)
DNA
, vol.6
, pp. 511-517
-
-
Fortkamp, E.1
Reiger, M.2
Heisterberg-Moustes, G.3
Schweitzer, S.4
Sommer, R.5
-
8
-
-
0022543853
-
Expression, secretion and processing of hirudin in E. coli using the alkaline phosphatase signal sequence
-
Dodt J, Schmitz T, Schafer T, Bergmann C. Expression, secretion and processing of hirudin in E. coli using the alkaline phosphatase signal sequence. FEBS Lett 1986; 202: 373-7
-
(1986)
FEBS Lett
, vol.202
, pp. 373-377
-
-
Dodt, J.1
Schmitz, T.2
Schafer, T.3
Bergmann, C.4
-
9
-
-
0024356740
-
Anticoagulant activity of synthetic hirudin peptides
-
Maraganore JM, Chao B, Joseph ML, Jablonski J, Ramachandran KL. Anticoagulant activity of synthetic hirudin peptides. J Biol Chem 1989; 264: 8692-8.
-
(1989)
J Biol Chem
, vol.264
, pp. 8692-8698
-
-
Maraganore, J.M.1
Chao, B.2
Joseph, M.L.3
Jablonski, J.4
Ramachandran, K.L.5
-
10
-
-
0025346345
-
Design and characterization of hirulogs: A novel class of bivalent peptide inhibitors of thrombin
-
Maraganore JM, Bourdon P, Jablonski J, Ramachandran KL, Fenton JW III. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry 1990; 29. 7095-101.
-
(1990)
Biochemistry
, vol.29
, pp. 7095-7101
-
-
Maraganore, J.M.1
Bourdon, P.2
Jablonski, J.3
Ramachandran, K.L.4
Fenton III, J.W.5
-
11
-
-
0021262284
-
Heparin-associated thrombocytopenia
-
King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med 1984; 100: 535-40
-
(1984)
Ann Intern Med
, vol.100
, pp. 535-540
-
-
King, D.J.1
Kelton, J.G.2
-
12
-
-
0018758825
-
White clot syndrome. Peripheral vascular complications of heparin therapy
-
Towne JB, Bernhard VM, Hussey C, Garancis JC. White clot syndrome. Peripheral vascular complications of heparin therapy. Arch Surg 1979; 114: 372-7.
-
(1979)
Arch Surg
, vol.114
, pp. 372-377
-
-
Towne, J.B.1
Bernhard, V.M.2
Hussey, C.3
Garancis, J.C.4
-
13
-
-
0024416485
-
Development of hirudin as an antithrombotic agent
-
Markwardt F. Development of hirudin as an antithrombotic agent. Sem Thromb Haemost 1989; 15: 269-82.
-
(1989)
Sem Thromb Haemost
, vol.15
, pp. 269-282
-
-
Markwardt, F.1
-
14
-
-
0025941325
-
Leeches, snakes, ticks and vampire bats in today's cardiovascular drug development
-
Bang NU. Leeches, snakes, ticks and vampire bats in today's cardiovascular drug development. Circulation 1991; 84: 436-8.
-
(1991)
Circulation
, vol.84
, pp. 436-438
-
-
Bang, N.U.1
-
15
-
-
0027443580
-
Selective thrombin inhibitors: The next generation of anticoagulants
-
Deutsch E, Rao AK, Colman RW. Selective thrombin inhibitors: The next generation of anticoagulants. JACC 1993; 22: 1089-92.
-
(1993)
JACC
, vol.22
, pp. 1089-1092
-
-
Deutsch, E.1
Rao, A.K.2
Colman, R.W.3
-
16
-
-
0024462894
-
Thrombin interactions with hirudin
-
Fenton JW II. Thrombin interactions with hirudin. Sem Thromb Haemost 1989; 15: 265-8.
-
(1989)
Sem Thromb Haemost
, vol.15
, pp. 265-268
-
-
Fenton II, J.W.1
-
17
-
-
49049125989
-
Thrombin activity of fibrin thrombi and soluble plasmic derivatives
-
Francis CW, Markham RE Jr, Barlow GH, Florack TM, Dobrzynski DM, Marder VJ. Thrombin activity of fibrin thrombi and soluble plasmic derivatives. J Lab Clin Med 1983; 102: 220-30.
-
(1983)
J Lab Clin Med
, vol.102
, pp. 220-230
-
-
Francis, C.W.1
Markham Jr., R.E.2
Barlow, G.H.3
Florack, T.M.4
Dobrzynski, D.M.5
Marder, V.J.6
-
18
-
-
0025146426
-
Clot-blound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors
-
Weitz JI, Hudoba M, Massel D, Maraganore JM, Hirsh J Clot-blound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990; 86: 385-91
-
(1990)
J Clin Invest
, vol.86
, pp. 385-391
-
-
Weitz, J.I.1
Hudoba, M.2
Massel, D.3
Maraganore, J.M.4
Hirsh, J.5
-
19
-
-
0021320067
-
Inhibition of the thrombin-platelet reaction by hirudin
-
Hoffman A, Markwardt F. Inhibition of the thrombin-platelet reaction by hirudin. Haemostasis 1984; 14: 164-9.
-
(1984)
Haemostasis
, vol.14
, pp. 164-169
-
-
Hoffman, A.1
Markwardt, F.2
-
20
-
-
0025908862
-
Hirudin and platelets
-
Glusa E. Hirudin and platelets. Sem Thromb Haemost 1991; 17: 122-5.
-
(1991)
Sem Thromb Haemost
, vol.17
, pp. 122-125
-
-
Glusa, E.1
-
21
-
-
0025174706
-
Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin
-
Jakubowski JA, Maraganore JM. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin. Blood 1990; 75: 399-406.
-
(1990)
Blood
, vol.75
, pp. 399-406
-
-
Jakubowski, J.A.1
Maraganore, J.M.2
-
22
-
-
0024582671
-
Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor
-
Heras MD, Chesebro JH, Penney WJ, Bailey KR, Badimon L, Fuster V. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation 1989; 79: 657-65.
-
(1989)
Circulation
, vol.79
, pp. 657-665
-
-
Heras, M.D.1
Chesebro, J.H.2
Penney, W.J.3
Bailey, K.R.4
Badimon, L.5
Fuster, V.6
-
23
-
-
0026073345
-
Hirudin interruption of heparin-resistant arterial thrombus formation in baboons
-
Kelly AB, Marzec UM, Krupski W, Bass A, Cadroy Y, Hanson SR, Harker LA. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood 1991; 77: 1006-12.
-
(1991)
Blood
, vol.77
, pp. 1006-1012
-
-
Kelly, A.B.1
Marzec, U.M.2
Krupski, W.3
Bass, A.4
Cadroy, Y.5
Hanson, S.R.6
Harker, L.A.7
-
24
-
-
0025233926
-
The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits
-
Agnelli G, Pascucci C, Cosmi B, Nenci GG. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits. Thromb Haemost 1990; 63: 204-7.
-
(1990)
Thromb Haemost
, vol.63
, pp. 204-207
-
-
Agnelli, G.1
Pascucci, C.2
Cosmi, B.3
Nenci, G.G.4
-
25
-
-
0026720153
-
The effect of thrombin inhibitors on tissue plasminogen activator induced thrombolysis in a rat model
-
Klement P, Brom A, Hirsh J, Maraganore J, Wilson G, Weitz J. The effect of thrombin inhibitors on tissue plasminogen activator induced thrombolysis in a rat model. Thromb Haemost 1992; 68: 64-8.
-
(1992)
Thromb Haemost
, vol.68
, pp. 64-68
-
-
Klement, P.1
Brom, A.2
Hirsh, J.3
Maraganore, J.4
Wilson, G.5
Weitz, J.6
-
26
-
-
0024311516
-
Antithrombotic activity of recombinant hirudin in the rat: A comparative study with heparin
-
Doutremepuich C, Deharo E, Guyot M, Lalanne MC, Walenga J, Fareed J. Antithrombotic activity of recombinant hirudin in the rat: A comparative study with heparin. Thromb Res 1989; 54: 435-45.
-
(1989)
Thromb Res
, vol.54
, pp. 435-445
-
-
Doutremepuich, C.1
Deharo, E.2
Guyot, M.3
Lalanne, M.C.4
Walenga, J.5
Fareed, J.6
-
27
-
-
0026704820
-
An animal model of fibrinolytic bleeding based on the rebleed phenomenon: Application to a study of vulnerability of hemostatic plugs of different age
-
Marder VJ, Shortell CK, Fitzpatrick PG, Kim C, Oxley D. An animal model of fibrinolytic bleeding based on the rebleed phenomenon: Application to a study of vulnerability of hemostatic plugs of different age. Thromb Res 1992; 67: 31-40.
-
(1992)
Thromb Res
, vol.67
, pp. 31-40
-
-
Marder, V.J.1
Shortell, C.K.2
Fitzpatrick, P.G.3
Kim, C.4
Oxley, D.5
-
28
-
-
0024438178
-
Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: Some objective considerations
-
Walenga JM, Pifarre R, Hoppensteadt DA, Fareed J. Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: Some objective considerations. Sem Thromb Haemost 1989; 15: 316-33.
-
(1989)
Sem Thromb Haemost
, vol.15
, pp. 316-333
-
-
Walenga, J.M.1
Pifarre, R.2
Hoppensteadt, D.A.3
Fareed, J.4
-
29
-
-
0022465230
-
Antithrombotic and haemorrhagic effects of synthetic and naturally occurring thrombin inhibitors
-
Kaiser B, Markwardt F. Antithrombotic and haemorrhagic effects of synthetic and naturally occurring thrombin inhibitors. Thromb Res 1986; 43: 613-20.
-
(1986)
Thromb Res
, vol.43
, pp. 613-620
-
-
Kaiser, B.1
Markwardt, F.2
-
30
-
-
0024344275
-
Studies on antithrombotic effects of recombinant hirudin
-
Markwardt F, Kaiser B, Nowak G. Studies on antithrombotic effects of recombinant hirudin. Thromb Res 1989; 54: 377-88.
-
(1989)
Thromb Res
, vol.54
, pp. 377-388
-
-
Markwardt, F.1
Kaiser, B.2
Nowak, G.3
-
31
-
-
0025875792
-
Anticoagulant and antithrombotic actions of recombinant hirudin
-
Kaiser B. Anticoagulant and antithrombotic actions of recombinant hirudin. Sem Thromb Haemost 1991; 17: 130-6.
-
(1991)
Sem Thromb Haemost
, vol.17
, pp. 130-136
-
-
Kaiser, B.1
-
32
-
-
0028037517
-
Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes
-
The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation 1994; 90: 1631-7.
-
(1994)
Circulation
, vol.90
, pp. 1631-1637
-
-
-
33
-
-
0028092111
-
Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial
-
Antman EM for the TIMI 9A Investigators. Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial. Circulation 1994; 90: 1624-30.
-
(1994)
Circulation
, vol.90
, pp. 1624-1630
-
-
-
34
-
-
0027964241
-
Direct thrombin inhibition with rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement
-
Eriksson BI, Kälebo P, Ekman S, Lindbratt S, Kerry R, Close P. Direct thrombin inhibition with rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement. Thromb Haemost 1994; 72: 227-31.
-
(1994)
Thromb Haemost
, vol.72
, pp. 227-231
-
-
Eriksson, B.I.1
Kälebo, P.2
Ekman, S.3
Lindbratt, S.4
Kerry, R.5
Close, P.6
-
35
-
-
0028273524
-
A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis
-
Schiele F, Vuillemenot A, Kramarz P, Kieffer Y, Soria J, Soria C, Camez A, Mirshahi MC, Bassand JP. A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis. Thromb Haemost 1994; 71: 558-62.
-
(1994)
Thromb Haemost
, vol.71
, pp. 558-562
-
-
Schiele, F.1
Vuillemenot, A.2
Kramarz, P.3
Kieffer, Y.4
Soria, J.5
Soria, C.6
Camez, A.7
Mirshahi, M.C.8
Bassand, J.P.9
-
36
-
-
0027985641
-
Use of hirulog in the prevention of venous thrombosis after major hip or knee surgery
-
Ginsberg JS, Nurmohamed MT, Gent M, MacKinnon B, Sicurella J, Brill-Edwards P, Levine MN, Panju AA, Powers P, Stevens P, Turpie AGG, Weitz J, Büller HR, ten Cate JW, Neemeh J, Adelman B, Fox I, Maraganore J, Hirsh J. Use of hirulog in the prevention of venous thrombosis after major hip or knee surgery. Circulation 1994; 90: 2385-9.
-
(1994)
Circulation
, vol.90
, pp. 2385-2389
-
-
Ginsberg, J.S.1
Nurmohamed, M.T.2
Gent, M.3
MacKinnon, B.4
Sicurella, J.5
Brill-Edwards, P.6
Levine, M.N.7
Panju, A.A.8
Powers, P.9
Stevens, P.10
Turpie, A.G.G.11
Weitz, J.12
Büller, H.R.13
Ten Cate, J.W.14
Neemeh, J.15
Adelman, B.16
Fox, I.17
Maraganore, J.18
Hirsh, J.19
-
37
-
-
0023845971
-
Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects
-
MacGregor IR, Roberts EM, Prowse CV, Broomhead AF, Ozolins M, Litka P. Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects. Thromb Haemost 1988; 59: 34-9.
-
(1988)
Thromb Haemost
, vol.59
, pp. 34-39
-
-
MacGregor, I.R.1
Roberts, E.M.2
Prowse, C.V.3
Broomhead, A.F.4
Ozolins, M.5
Litka, P.6
-
38
-
-
0028281027
-
DDAVP shortens bleeding time in Bernard-Soulier syndrome
-
Kemahli S, Canatan D, Uysal U, Akar N, Cin S, Arcasoy A. DDAVP shortens bleeding time in Bernard-Soulier syndrome. Thromb Haemost 1994; 71: 675-6.
-
(1994)
Thromb Haemost
, vol.71
, pp. 675-676
-
-
Kemahli, S.1
Canatan, D.2
Uysal, U.3
Akar, N.4
Cin, S.5
Arcasoy, A.6
-
39
-
-
0344481820
-
Some therapeutic agents influencing hemostasis
-
Colman RM, Hirsh J, Marder VJ, Salzman EW, eds. JB Lippincott, Inc., Philadelphia. PA
-
Ratnoff OD. Some therapeutic agents influencing hemostasis. In: Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 3rd ed. Colman RM, Hirsh J, Marder VJ, Salzman EW, eds. JB Lippincott, Inc., Philadelphia. PA, 1994; pp 1104-33.
-
(1994)
Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 3rd Ed.
, pp. 1104-1133
-
-
Ratnoff, O.D.1
-
40
-
-
0025981535
-
The influence of infusions of 1-desamino-8-D-arginine vasopression (DDAVP) in vivo on the anticoagulant effect of recombinant hirudin (CGP 39393) in vitro
-
Ibbotson SH, Grant PJ, Kerry R, Findlay VS, Prentice CRM. The influence of infusions of 1-desamino-8-D-arginine vasopression (DDAVP) in vivo on the anticoagulant effect of recombinant hirudin (CGP 39393) in vitro. Thromb Haemost 1991; 65: 64-6.
-
(1991)
Thromb Haemost
, vol.65
, pp. 64-66
-
-
Ibbotson, S.H.1
Grant, P.J.2
Kerry, R.3
Findlay, V.S.4
Prentice, C.R.M.5
-
41
-
-
0027255837
-
Factor VIII and DDAVP reverse the effect of recombinant desulphatohirudin (CGP 39393) on bleeding in the rat
-
Butler KD, Dolan SL, Talbot MD, Wallis RB. Factor VIII and DDAVP reverse the effect of recombinant desulphatohirudin (CGP 39393) on bleeding in the rat. Blood Coag Fibrinoly 1993; 4: 459-64.
-
(1993)
Blood Coag Fibrinoly
, vol.4
, pp. 459-464
-
-
Butler, K.D.1
Dolan, S.L.2
Talbot, M.D.3
Wallis, R.B.4
-
42
-
-
0028966026
-
Reversal of hirudin-induced bleeding diathesis by prothrombin complex concentrate
-
Irani MS, White HJ Jr, Sexon RG. Reversal of hirudin-induced bleeding diathesis by prothrombin complex concentrate. Am J Cardiol 1995; 75: 422-3.
-
(1995)
Am J Cardiol
, vol.75
, pp. 422-423
-
-
Irani, M.S.1
White Jr., H.J.2
Sexon, R.G.3
-
43
-
-
0027209030
-
Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty
-
Topol EJ, Bonan R, Jewitt D, Sigwart U, Kakker VV, Rothman M, de Bono D, Ferguson J, Willerson JT, Strony J, Ganz P, Cohen MD, Raymond R, Fox I, Maraganore J, Adeiman B. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty. Circulation 1993; 87: 1622-9.
-
(1993)
Circulation
, vol.87
, pp. 1622-1629
-
-
Topol, E.J.1
Bonan, R.2
Jewitt, D.3
Sigwart, U.4
Kakker, V.V.5
Rothman, M.6
De Bono, D.7
Ferguson, J.8
Willerson, J.T.9
Strony, J.10
Ganz, P.11
Cohen, M.D.12
Raymond, R.13
Fox, I.14
Maraganore, J.15
Adeiman, B.16
-
44
-
-
0027361488
-
Recombinant hirudin in patients with chronic, stable coronary artery disease. Safety, half-life, and effect on coagulation parameters
-
Zoldhelyi P, Webster MWI, Fuster V, Grill DE, Gaspar D, Edwards SJ, Cabot CF, Chesebro JH. Recombinant hirudin in patients with chronic, stable coronary artery disease. Safety, half-life, and effect on coagulation parameters. Circulation 1993; 88: 2015-22.
-
(1993)
Circulation
, vol.88
, pp. 2015-2022
-
-
Zoldhelyi, P.1
Webster, M.W.I.2
Fuster, V.3
Grill, D.E.4
Gaspar, D.5
Edwards, S.J.6
Cabot, C.F.7
Chesebro, J.H.8
-
45
-
-
0027497137
-
Initial experience with a direct antithrombin, hirulog, in unstable angina. Anti-coagulant, antithrombotic and clinical effects
-
Lidon R-M, Théroux P, Juneau M, Adeiman B, Maraganore J. Initial experience with a direct antithrombin, hirulog, in unstable angina. Anti-coagulant, antithrombotic and clinical effects. Circulation 1993; 88: 1495-501.
-
(1993)
Circulation
, vol.88
, pp. 1495-1501
-
-
Lidon, R.-M.1
Théroux, P.2
Juneau, M.3
Adeiman, B.4
Maraganore, J.5
|